Connect with us

Legal & Regulation

A Proposed Amendment to Psychedelics Continues Onward Yet Cannabis Proposal Gets Denied

Jane S

Published

on

A Proposed Amendment to Psychedelics Continues Onward Yet Cannabis Proposal Gets Denied

A proposed amendment to a large-scale spending bill that funds portions of the government during the 2020 Fiscal Year, introduced by Representative Alexandria Ocasio-Cortez (D-NY), may have a significant impact on the study of psilocybin and MDMA. Psilocybin is the active compound in “magic shrooms,” while MDMA is ecstasy. According to the proposed amendment, these substances have “shown promise in end of life therapy and treating PTSD.”

If the amendment is approved, a provision to the spending bill that prohibits spending federal funds on “any activity that promotes the legalization of any drug or other substance in Schedule I” of the Controlled Substances Act would be eliminated.

Ocasio-Cortez tweeted about the amendment, stated “From the opioid crisis to psilocybin’s potential w/ PTSD, it’s well past time we take drug use out of criminal consideration + into medical consideration. That begins with research. I’m proud to introduce an amendment that helps scientists do their jobs.”

Another amendment was filed by Rep. Lou Correa (D-CA) concerning the spending bill. His amendment would prevent the Department of Education from moving “to deny or limit any funding or assistance to institutions of higher education” allowing for the use or possession of medical marijuana in states where the substance has been legalized. Pedro Padilla, the University of Utah NORML Director, shared with Marijuana Moment, “It is frustrating that patients who are seeking to improve their position in life by attending college would be forced to choose between their education and their medication,”

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Join Us On Facebook

Trending CBD News

TimesofCBD always fact checks sources and aims for the best accuracy in the reporting curated cannabis content consisting of the latest CBD news, user guides and product health research. Quality is the priority, but we are not eligible to be liable as everything here is for educational, informational purposes only. Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.

What Is CBD?

Copyright © 2019 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends: Telegram